Stockreport

Loss-Making RenovoRx, Inc. (NASDAQ:RNXT) Expected To Breakeven In The Medium-Term [Yahoo! Finance]

RenovoRx, Inc.  (RNXT) 
PDF RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patien [Read more]